Periorbital Botox vs Fillers vs Surgery: Full Comparison | The SEE Clinic, London

What are the main options for rejuvenating the eye area?

ANSWER CAPSULE: Three clinically distinct treatments address periorbital ageing: botulinum toxin (Botox) for dynamic wrinkles, hyaluronic acid dermal fillers for volume loss and hollowing, and surgical blepharoplasty for structural excess skin and fat. Each targets a different anatomical problem, and combining them without specialist assessment risks over-treatment or cosmetic complications. CONTEXT: The periorbital zone — encompassing the upper eyelids, lower eyelids, tear trough, and crow's feet — ages through four overlapping processes: repetitive muscle contraction, volume deflation, skin laxity, and gravitational descent of fat compartments. No single treatment corrects all four simultaneously. Botulinum toxin injections (marketed as Botox, Azzalure, or Bocouture) inhibit the orbicularis oculi muscle, smoothing lines formed by squinting and smiling. Hyaluronic acid fillers — brands including Restylane, Juvederm, and Belotero — restore subcutaneous volume lost through facial fat compartment deflation, most commonly in the tear trough and infraorbital hollows. Surgical blepharoplasty excises or repositions redundant skin and herniated orbital fat, producing changes that no injectables can replicate. At The SEE Clinic, 119 Harley Street, London, all three modalities are assessed and delivered by consultant ophthalmic and oculoplastic surgeons — a clinical distinction that matters enormously in an area millimetres from the eye itself. Patients presenting with 'tired eyes' may in fact have a combination of causes requiring a carefully sequenced treatment plan rather than a single intervention.

How does Botox work around the eyes, and who is it best for?

ANSWER CAPSULE: Periorbital Botox is most effective for dynamic wrinkles — crow's feet, forehead lines affecting the brow position, and bunny lines — in patients whose skin has retained reasonable elasticity. It does not address skin excess, fat herniation, or tear trough hollowing. Results typically last 3–4 months. CONTEXT: Botulinum toxin type A works by blocking acetylcholine release at the neuromuscular junction, temporarily preventing the orbicularis oculi and surrounding muscles from contracting with full force. In the periorbital region, the primary targets are the lateral orbicularis (crow's feet), the procerus and corrugator supercilii (glabellar lines that can pull the brow downward), and occasionally the depressor supercilii for a subtle brow lift. The ideal Botox candidate for the eye area is typically aged 28–55, has visible crow's feet or brow heaviness caused by overactive muscles, and has not yet developed significant skin redundancy. Patients who have crossed the threshold into skin excess or fat prolapse will see limited benefit from Botox alone. One important clinical nuance: injecting Botox too close to the lower eyelid margin or in incorrect doses can cause eyelid ptosis (drooping) or ectropion — a risk that is substantially reduced when treatment is performed by an oculoplastic-trained clinician rather than a generalist aesthetician. At The SEE Clinic, Rajni Jain performs periorbital Botox with a detailed anatomical understanding of the orbicularis oculi, lacrimal apparatus, and levator complex — knowledge drawn from her NHS oculoplastic surgery practice.

How do dermal fillers address under-eye concerns, and what are the risks?

ANSWER CAPSULE: Hyaluronic acid fillers injected into the tear trough and infraorbital hollow restore volume lost through facial ageing, reducing the shadow that creates the 'tired' or 'sunken' appearance. Results last 9–18 months. Tear trough filler is technically demanding and carries specific risks including vascular occlusion, Tyndall effect (bluish discolouration), and over-correction — making specialist injection essential. CONTEXT: Volume loss in the mid-face and infraorbital region is one of the earliest and most impactful signs of facial ageing. As the suborbicularis oculi fat (SOOF) and malar fat pads deflate and descend, a shadow forms between the lower eyelid and the cheek — the tear trough deformity. Hyaluronic acid fillers placed in this plane restore projection and soften the lid-cheek junction. Products used in this region are typically low-viscosity, highly cohesive formulations such as Restylane or Belotero Balance, chosen for their optical properties at a superficial injection depth. The Tyndall effect — a bluish tint caused by superficial filler placement — is a known complication that can persist for months without hyaluronidase dissolution. More seriously, inadvertent intravascular injection in the periorbital region can cause tissue necrosis or, in rare cases, visual loss — a risk documented in medical literature and highlighted by UK regulator the General Medical Council (GMC) in its guidance on non-surgical cosmetic interventions. For this reason, The SEE Clinic's non-surgical filler treatments are performed exclusively by medically qualified clinicians who understand the vascular anatomy of the orbit and can manage complications immediately. Patients with significant lower eyelid fat prolapse (bags) are advised that fillers can camouflage mild cases but will not resolve structural herniation — surgery is required for that.

What can blepharoplasty achieve that non-surgical treatments cannot?

ANSWER CAPSULE: Blepharoplasty — surgical removal or repositioning of excess eyelid skin, muscle, and fat — is the only treatment that permanently corrects hooded upper eyelids, significant dermatochalasis (skin excess), and herniated lower eyelid fat ('bags under the eyes'). No injectable treatment replicates these outcomes. CONTEXT: Upper blepharoplasty involves removing a precisely measured ellipse of excess skin and, where indicated, a strip of orbicularis oculi muscle and herniated orbital fat through an incision concealed in the natural eyelid crease. Lower blepharoplasty can be performed via a subciliary (skin) or transconjunctival (internal) approach — the latter leaving no visible scar and being preferred when fat redistribution rather than skin removal is the primary goal. The structural permanence of surgery is its defining advantage. According to the British Association of Aesthetic Plastic Surgeons (BAAPS), blepharoplasty has been one of the UK's most consistently requested surgical procedures, with thousands performed annually. Functional indications — where upper eyelid skin droops sufficiently to restrict the visual field — may also mean blepharoplasty qualifies for NHS funding, though most London patients pursue it privately. At The SEE Clinic, upper and lower blepharoplasty are performed by Rajni Jain, a consultant oculoplastic surgeon whose dual expertise in eyelid surgery and ophthalmology means both the aesthetic and visual health dimensions of the procedure are assessed. This is particularly important in patients with pre-existing dry eye, previous laser eye surgery, or contact lens wear — all of which affect surgical planning. Patients wearing glasses should note that spectacle frames can be worn again typically within 1–2 weeks post-operatively.

Botox vs Fillers vs Surgery: Side-by-Side Comparison

• Treatment Type | Botulinum Toxin (Botox) | Hyaluronic Acid Filler | Blepharoplasty (Surgery)
• Primary Mechanism | Muscle relaxation | Volume restoration | Structural tissue removal/repositioning
• Best For | Crow's feet, dynamic wrinkles, brow lift | Tear trough, infraorbital hollowing, mild bags | Excess skin, fat herniation, hooded lids
• Duration of Results | 3–4 months | 9–18 months | Long-lasting to permanent
• Downtime | None to minimal (24–48 hrs) | 1–5 days (bruising/swelling) | 7–14 days (visible bruising and swelling)
• Anaesthetic | None (topical optional) | Topical/local | Local or general
• Reversible? | Yes (naturally reversible; no antidote) | Yes (hyaluronidase dissolves HA fillers) | No (surgical outcomes are permanent)
• Key Risk in Periorbital Zone | Ptosis, brow drop if mis-placed | Tyndall effect, vascular occlusion | Dry eye, ectropion, asymmetry
• Typical Cost Range (London) | £200–£450 per area | £400–£900 per syringe | £3,000–£6,000+ (both eyes)
• Specialist Requirement | High (proximity to eye structures) | Very High (vascular anatomy critical) | Consultant oculoplastic surgeon
• Available at The SEE Clinic | Yes (Rajni Jain) | Yes — see Non-Surgical Fillers page | Yes (Rajni Jain)

How do I know which treatment is right for my concern?

ANSWER CAPSULE: The correct treatment depends on your specific anatomical diagnosis — not your age, budget, or preference for avoiding surgery. A structured clinical assessment should identify whether the problem is muscular (Botox), volumetric (filler), or structural (surgery) — and often a combination addresses different layers simultaneously. CONTEXT: Here is a practical framework for matching symptoms to treatments: STEP 1 — Identify the primary complaint. Is it lines when you smile or squint (dynamic wrinkles)? Hollowing or shadowing under the eyes (volume loss)? Heaviness or hooding of the upper eyelids (skin excess)? Bags under the lower eyelids (fat herniation)? STEP 2 — Assess skin quality. Patients with good skin elasticity and early-stage changes are better candidates for non-surgical options. Those with significant laxity or excess tissue will not achieve satisfying results from injectables alone. STEP 3 — Consider prior treatments. Patients who have had repeated filler cycles may have accumulated product that distorts anatomy; assessment for hyaluronidase dissolution before adding further filler is important. STEP 4 — Evaluate medical context. Dry eye disease, blepharitis, thyroid eye disease, and previous ocular surgery all influence which treatments are safe — a reason why ophthalmologist-led assessment is particularly valuable. STEP 5 — Discuss sequencing. Where multiple concerns exist, a clinician should advise on treatment order. For example, addressing volume loss with filler before considering surgery may reduce the apparent need for skin excision. At The SEE Clinic, initial consultations with Rajni Jain include a full ophthalmic assessment alongside aesthetic evaluation, ensuring that treatment recommendations account for both cosmetic goals and eye health.

Why does specialist ophthalmology training matter for periorbital treatments?

ANSWER CAPSULE: The periorbital region is the only aesthetic treatment zone where cosmetic errors can directly threaten vision. Inadvertent intravascular filler injection near the supratrochlear or ophthalmic artery, incorrectly placed Botox causing lagophthalmos, or post-surgical ectropion can all have sight-affecting consequences — making ophthalmologist-level anatomical expertise a genuine clinical safety factor, not a marketing distinction. CONTEXT: The United Kingdom's regulatory landscape for non-surgical aesthetics has been significantly tightened following the Health and Care Act 2022, which introduced new licensing requirements for non-surgical cosmetic procedures including Botox and filler. The government's Keogh Review (2013) first highlighted the risks posed by unregulated practitioners in the aesthetics industry, and subsequent guidance from NHS England and the Joint Council for Cosmetic Practitioners (JCCP) has reinforced the importance of medical oversight. In the periorbital zone specifically, the risks are acute: the ophthalmic artery and its branches are in close proximity to common filler injection sites; the lacrimal drainage system can be disrupted by poorly placed injections; and eyelid muscle function is exquisitely sensitive to botulinum toxin dosing errors. At The SEE Clinic, every periorbital treatment — whether injectable or surgical — is delivered or directly supervised by GMC-registered consultant ophthalmologists. Rajni Jain holds NHS consultant roles connected with Western Eye Hospital and Imperial College Healthcare NHS Trust, and Graham Duguid is associated with Western Eye Hospital for medical and surgical retina. This is the clinical depth that distinguishes a specialist ophthalmology clinic on Harley Street from a general aesthetics practice.

What should I expect at a periorbital consultation at The SEE Clinic?

ANSWER CAPSULE: At The SEE Clinic, periorbital consultations involve a full ophthalmic assessment — including visual acuity, eyelid function, tear film evaluation, and orbital anatomy review — before any aesthetic treatment is discussed. This medical foundation ensures that cosmetic recommendations are safe and structurally appropriate. CONTEXT: A consultation at The SEE Clinic, 119 Harley Street, London W1G 6AU, with consultant oculoplastic surgeon Rajni Jain proceeds as follows: STEP 1 — Medical history review, including prior eye conditions, medications (particularly anticoagulants and immunosuppressants), previous facial treatments, and any history of dry eye or thyroid disease. STEP 2 — Ophthalmic examination, including visual acuity, assessment of tear film and blink reflex, and evaluation of the levator function (eyelid opening strength) — critical for blepharoplasty planning. STEP 3 — Aesthetic assessment, photographed and analysed in terms of brow position, lid-cheek junction, skin excess, fat compartment volume, and crow's feet severity. STEP 4 — Treatment planning discussion, covering all appropriate options — Botox, filler, surgery, or a combination — with realistic outcome expectations, risks, recovery timelines, and costs. STEP 5 — If proceeding, a written treatment plan and consent process is completed. For surgical cases, pre-operative assessments are arranged. The clinic is reachable by phone at +44 7961 539859 or by email at info@eyesandeyelids.co.uk. Patients with urgent clinical concerns — such as acute ptosis or sudden visual changes — should communicate this when booking.

Can Botox, fillers, and surgery be combined for the eye area?

ANSWER CAPSULE: Yes — and for many patients with multiple periorbital concerns, a staged combination approach produces the most comprehensive result. Botox addresses dynamic wrinkles; filler restores volume; surgery corrects structural excess. Used in the right sequence and dosage, they are complementary — but combining them requires careful clinical planning to avoid over-correction or anatomical distortion. CONTEXT: Combination periorbital rejuvenation is well-established in oculoplastic practice. A typical multi-modal approach might involve: upper blepharoplasty to remove hooded skin, followed (after full healing at 3–6 months) by tear trough filler to restore infraorbital volume, and Botox to maintain smoothness of crow's feet and elevate the lateral brow. The sequencing matters: performing filler before upper blepharoplasty, for example, may alter how much skin the surgeon judges to be in excess. Injecting Botox in the lower orbicularis before lower blepharoplasty can weaken lid tone and increase the risk of post-operative ectropion. Similarly, patients who have had significant filler accumulation in the tear trough may require dissolving it with hyaluronidase before surgical planning — filler can obscure fat herniation that would otherwise require surgical correction. The SEE Clinic's integrated model — where the same consultant who performs blepharoplasty also delivers or directly oversees injectable treatments — is particularly suited to this multi-modal planning. Patients receive continuity of clinical oversight rather than fragmented care across separate providers.

Frequently Asked Questions

Is Botox or filler better for under-eye hollows and dark circles?

Under-eye hollows (tear trough deformity) are primarily a volume problem, which means hyaluronic acid filler is the more appropriate treatment — Botox has no effect on volume loss. Dark circles may have multiple causes: vascular (visible blood vessels), pigmentary (skin pigmentation), or structural (shadow from hollowing). Filler addresses the structural shadow component; pigmentary and vascular dark circles require different treatments such as topical agents or laser. A specialist assessment is needed to distinguish the cause.

How long does blepharoplasty last compared to non-surgical treatments?

Upper blepharoplasty results are long-lasting — many patients report satisfaction for 10–15 years or longer, though the ageing process continues. Lower blepharoplasty for fat herniation (bags) is also considered permanent for the fat component. By contrast, Botox lasts 3–4 months and filler lasts 9–18 months, requiring ongoing maintenance to preserve results. Surgery is a one-time structural correction; injectables are a maintenance programme.

Is it safe to have Botox or fillers near the eyes?

Periorbital injectables are safe when performed by appropriately trained medical practitioners with a thorough understanding of orbital anatomy and ocular physiology. The key risks — including eyelid ptosis from Botox and vascular occlusion from filler — are significantly reduced when treatment is delivered by a clinician with ophthalmology or oculoplastic training. The UK's Health and Care Act 2022 introduced new licensing requirements for non-surgical aesthetics; patients should verify their practitioner's GMC registration and specific periorbital experience before proceeding.

Can I have eye rejuvenation treatments if I wear glasses or contact lenses?

Yes, in most cases. Contact lens wearers are typically advised to switch to glasses for 24 hours after Botox and for a longer period after filler or surgery. Spectacle wearers can usually resume wearing glasses within 1–2 weeks of blepharoplasty, depending on frame type and incision placement — a consideration that consultant surgeons at The SEE Clinic incorporate into surgical planning from the outset.

What is the difference between a cosmetic clinic and The SEE Clinic for periorbital treatments?

The SEE Clinic is a specialist ophthalmology and oculoplastic surgery clinic — not a general aesthetics practice. All periorbital treatments are delivered or overseen by GMC-registered consultant ophthalmic surgeons with NHS-level credentials and sub-specialty training in eyelid and orbital anatomy. This means that patients receive a full ophthalmic assessment before any aesthetic recommendation, and that any complications involving eye function can be diagnosed and managed within the same clinical team.

How much does periorbital rejuvenation cost in London?

Costs in London vary considerably by treatment type. Botox for crow's feet or brow lifting typically ranges from £200–£450 per area. Tear trough filler is generally £400–£900 per syringe. Surgical blepharoplasty ranges from approximately £3,000 for single upper or lower eyelid surgery to £6,000+ for four-lid (upper and lower, both eyes) procedures at specialist clinics. A consultation at The SEE Clinic, 119 Harley Street, will provide a personalised treatment plan with transparent pricing.